These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20538166)

  • 1. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.
    Nicholls SJ; Tuzcu EM; Wolski K; Bayturan O; Lavoie A; Uno K; Kupfer S; Perez A; Nesto R; Nissen SE
    J Am Coll Cardiol; 2011 Jan; 57(2):153-9. PubMed ID: 21211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
    Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors for progression of nonintervened nonculprit coronary lesions despite low-density lipoprotein cholesterol less than 1.8 mmol/l after successful stent implantation.
    Yin ZX; Zhou YJ; Liu XL; Han HY; Yang SW
    Coron Artery Dis; 2011 Mar; 22(1):49-54. PubMed ID: 21150778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
    von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
    Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
    Kataoka Y; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    J Am Coll Cardiol; 2012 May; 59(18):1592-7. PubMed ID: 22538329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.
    Puri R; Nissen SE; Shao M; Elshazly MB; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2220-2228. PubMed ID: 27515380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
    Puri R; Nissen SE; Somaratne R; Cho L; Kastelein JJ; Ballantyne CM; Koenig W; Anderson TJ; Yang J; Kassahun H; Wasserman SM; Scott R; Borgman M; Nicholls SJ
    Am Heart J; 2016 Jun; 176():83-92. PubMed ID: 27264224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale of decreasing low-density lipoprotein cholesterol below 70 mg/dL in patients with coronary artery disease: A retrospective virtual histology-intravascular ultrasound study.
    Seo YH; Seo DJ; Song IG; Kim KH; Kwon TG; Bae JH
    Cardiol J; 2018; 25(6):674-682. PubMed ID: 29341060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.
    Shin S; Park HB; Chang HJ; Arsanjani R; Min JK; Kim YJ; Lee BK; Choi JH; Hong GR; Chung N
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):437-446. PubMed ID: 27771404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels.
    Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Murat Tuzcu E; Nissen SE; Nicholls SJ
    Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.